KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Non-Current Deferred Tax Liability (2018 - 2026)

Takeda Pharmaceutical has reported Non-Current Deferred Tax Liability over the past 9 years, most recently at $170.9 million for Q1 2026.

  • For Q1 2026, Non-Current Deferred Tax Liability fell 25.82% year-over-year to $170.9 million; the TTM value through Mar 2026 reached $170.9 million, down 25.82%, while the annual FY2026 figure was $178.1 million, 22.84% down from the prior year.
  • Non-Current Deferred Tax Liability was $170.9 million for Q1 2026 at Takeda Pharmaceutical, down from $230.4 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $3.9 billion in Q1 2022 and bottomed at $170.9 million in Q1 2026.
  • The 5-year median for Non-Current Deferred Tax Liability is $767.7 million (2024), against an average of $1.4 billion.
  • Year-over-year, Non-Current Deferred Tax Liability fell 24.24% in 2022 and then plummeted 69.99% in 2025.
  • Over 5 years, Non-Current Deferred Tax Liability stood at $3.9 billion in 2022, then tumbled by 47.34% to $2.0 billion in 2023, then plummeted by 62.47% to $767.7 million in 2024, then plummeted by 69.99% to $230.4 million in 2025, then dropped by 25.82% to $170.9 million in 2026.
  • The last three reported values for Non-Current Deferred Tax Liability were $170.9 million (Q1 2026), $230.4 million (Q1 2025), and $767.7 million (Q1 2024) per Business Quant data.